Osivelotor
- Generic Name
- Osivelotor
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H22N2O6
- CAS Number
- 2417955-18-9
- Unique Ingredient Identifier
- UK749B4S16
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 52
- Registration Number
- NCT06507904
A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT06340347
- Locations
- ๐บ๐ธ
Orange County Research Center, Lake Forest, California, United States
๐บ๐ธElixia EPCT, Tampa, Florida, United States
๐บ๐ธGenesis Clinical Research, LLC, Tampa, Florida, United States
GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 47
- Registration Number
- NCT05632354
- Locations
- ๐บ๐ธ
Edward Jenner Research Group LLC., Miami, Florida, United States
๐บ๐ธOur Lady of the Lake Hospital, Inc., Baton Rouge, Louisiana, United States
๐บ๐ธUniversity Medical Center Inpatient Pharmacy, New Orleans, Louisiana, United States
A Phase 2/3 Study in Adult and Pediatric Participants With SCD
- First Posted Date
- 2022-06-24
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 429
- Registration Number
- NCT05431088
- Locations
- ๐บ๐ธ
LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States
๐บ๐ธOur Lady of the Lake Hopistal, Inc, Baton Rouge, Louisiana, United States
๐บ๐ธOur lady of the Lake Hospital, Baton Rouge, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2024. All Rights Reserved by MedPath